文献速递产科母胎医学

糖尿病患者产时胰岛素方案的效果评估

Evaluation of an Intrapartum Insulin Regimen for Women With Diabetes.
PubMed 文献 · Obstet Gynecol · 2020-01-01

该项回顾性队列研究评估了糖尿病患者产时胰岛素标准化方案与结局的关系。方案实施后,产妇产时高血糖(51.3% vs 37.9%)和低血糖(6.1% vs 2.5%)频率均降低,但新生儿低血糖频率升高(36.6% vs 49.2%)。新生儿重症监护入住和静脉葡萄糖治疗无显著差异。

要点

  • 标准化胰岛素方案与产妇产时高血糖和低血糖频率降低相关。
  • 方案实施后新生儿低血糖频率升高(36.6% vs 49.2%)。
  • 新生儿重症监护入住率和静脉葡萄糖治疗需求无显著变化。

核心结论

  • 针对糖尿病产妇的正式胰岛素和葡萄糖输注管理方案与产时产妇血糖控制改善相关,但新生儿低血糖频率增加。

研究设计与样本

  • 回顾性队列研究,纳入在北western Memorial Hospital分娩活产新生儿的孕前或妊娠期糖尿病女性,比较2011年前后两个时间段:2005年1月至2010年12月(实施前)与2012年1月至2017年12月(实施后),排除2011年作为逐步引入期。
  • 共纳入3,689名女性,其中928名(25.2%)在2011年前分娩。

主要发现

  • 方案实施后,产妇产时高血糖频率从51.3%降至37.9%,低血糖频率从6.1%降至2.5%,均P<.001;调整后比值比分别为aOR 0.64(95% CI 0.54-0.77)和aOR 0.50(95% CI 0.33-0.78)。
  • 新生儿低血糖频率从36.6%升高至49.2%(P<.001;aOR 1.73,95% CI 1.45-2.07)。
  • 新生儿重症监护入住和静脉葡萄糖治疗需求在两个时间段相似。

关键数值与推荐

  • 产妇产时高血糖定义为血糖大于125 mg/dL。
  • 产妇低血糖定义为血糖小于60 mg/dL。
  • 新生儿低血糖定义为血糖小于50 mg/dL。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine whether an insulin protocol for intrapartum glucose control among parturients with diabetes was associated with improved outcomes. METHODS: This is a retrospective cohort study of women with pregestational or gestational diabetes delivering a liveborn neonate at Northwestern Memorial Hospital. Before 2011, women with diabetes were given intravenous (IV) insulin or glucose during labor at the discretion of the on-call endocrinologist. In 2011, a standardized protocol was designed to titrate insulin and glucose infusions. Outcomes were compared between two time periods: January 2005-December 2010 (before implementation) and January 2012-December 2017 (after implementation) with 2011 excluded to account for a phase-in period. Maternal outcomes included intrapartum hyperglycemia (blood glucose greater than 125 mg/dL) and hypoglycemia (blood glucose less than 60 mg/dL). Neonatal outcomes included hypoglycemia (blood glucose less than 50 mg/dL), intensive care admission, and IV dextrose therapy. t tests, Wilcoxon rank sum tests, and χ tests were used for bivariable analyses. Linear and logistic multivariable regression were used to account for confounding factors. RESULTS: Of 3,689 women, 928 (25.2%) delivered before 2011. After protocol implementation, frequencies of both maternal intrapartum hyperglycemia (51.3% vs 37.9%) and hypoglycemia decreased (6.1% vs 2.5%), both P<.001; respective adjusted odds ratio [aOR] 0.64, 95% CI 0.54-0.77 and 0.50, 95% CI 0.33-0.78. The frequency of neonatal hypoglycemia, however, increased (36.6% vs 49.2%, P<.001; aOR 1.73, 95% CI 1.45-2.07). Admission to the neonatal intensive care unit and need for IV dextrose therapy were similar across time periods. CONCLUSION: A formal protocol to manage insulin and glucose infusions for parturients with diabetes was associated with improved intrapartum maternal glucose control, but an increased frequency of neonatal hypoglycemia.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Dude AM, Niznik C, Peaceman AM, et al. Evaluation of an Intrapartum Insulin Regimen for Women With Diabetes. Obstet Gynecol. 2020. PMID: 32649492. doi:10.1097/AOG.0000000000003940

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。